Germline variant in REXO2 is a novel candidate gene in familial pheochromocytoma. (2020)

• Record Type: Journal Article
• Authors: Laitman, Yael; Tzur, Shay; Attali, Ruben; Tirosh, Amit; Friedman, Eitan
• Is Part Of: Genetical research. Volume 102(2020)
• Publication Date: 2020
• Subjects: inherited predisposition, -- pheochromocytoma, -- REXO2 gene, -- whole-exome sequencing; Genetics -- Periodicals; Heredity -- Periodicals; 576.5
• DOI: 10.1017/S0016672320000038
• Languages: English
• ISSNs: 0016-6723

Abstract

Abstract: Pheochromocytoma (PCC) is a rare, mostly benign tumour of the adrenal medulla. Hereditary PCC accounts for ~35% of cases and has been associated with germline mutations in several cancer susceptibility genes (e.g., KIF1B, SDHB, VHL, SDHD, RET ). We performed whole-exome sequencing in a family with four PCC-affected patients in two consecutive generations and identified a potential novel candidate pathogenic variant in the REXO2 gene that affects splicing (c.531-1G>T (NM 015523.3)), which co-segregated with the phenotype in the family. REXO2 encodes for RNA exonuclease 2 protein and localizes to 11q23, a chromosomal region displaying allelic imbalance in PCC. REXO2 protein has been associated with DNA repair, replication and recombination processes and thus its inactivation may contribute to tumorigenesis. While the study suggests that this novel REXO2 gene variant underlies PCC in this family, additional functional studies are required in order to establish the putative role of the REXO2 gene in PCC predisposition.